FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200592904> ?p ?o ?g. }

• W4200592904 abstract "Background: Perturbation of energy metabolism exacerbates cardiac dysfunction, serving as a potential therapeutic target in congestive heart failure. Although circulating free fatty acids (FFAs) are linked to insulin resistance and risk of coronary heart disease, it still remains unclear whether circulating FFAs are associated with the prognosis of patients with acute heart failure (AHF). Methods: This single-center, observational cohort study enrolled 183 AHF patients (de novo heart failure or decompensated chronic heart failure) in the Second Affiliated Hospital, Zhejiang University School of Medicine. All-cause mortality and heart failure (HF) rehospitalization within 1 year after discharge were investigated. Serum FFAs were modeled as quartiles as well as a continuous variable (per SD of FFAs). The restricted cubic splines and cox proportional hazards models were applied to evaluate the association between the serum FFAs level and all-cause mortality or HF rehospitalization. Results: During a 1-year follow-up, a total of 71 (38.8%) patients had all-cause mortality or HF rehospitalization. The levels of serum FFAs positively contributed to the risk of death or HF rehospitalization, which was not associated with the status of insulin resistance. When modeled with restricted cubic splines, the serum FFAs increased linearly for the incidence of death or HF rehospitalization. In a multivariable analysis adjusting for sex, age, body-mass index, coronary artery disease, diabetes mellitus, hypertension, left ventricular ejection fraction and N-terminal pro-brain natriuretic peptid, each SD (303.07 μmol/L) higher FFAs were associated with 26% higher risk of death or HF rehospitalization (95% confidence interval, 2-55%). Each increasing quartile of FFAs was associated with differentially elevated hazard ratios for death or HF rehospitalization of 1 (reference), 1.71 (95% confidence interval, [0.81, 3.62]), 1.41 (95% confidence interval, [0.64, 3.09]), and 3.18 (95% confidence interval, [1.53, 6.63]), respectively. Conclusion: Serum FFA levels at admission among patients with AHF were associated with an increased risk of adverse outcomes. Additional studies are needed to determine the causal-effect relationship between FFAs and acute cardiac dysfunction and whether FFAs could be a potential target for AHF management." @default.
• W4200592904 created "2021-12-31" @default.
• W4200592904 creator A5002588547 @default.
• W4200592904 creator A5004309205 @default.
• W4200592904 creator A5034321470 @default.
• W4200592904 creator A5034875129 @default.
• W4200592904 creator A5050638924 @default.
• W4200592904 creator A5070105880 @default.
• W4200592904 creator A5072129602 @default.
• W4200592904 creator A5087944559 @default.
• W4200592904 date "2021-12-22" @default.
• W4200592904 modified "2023-09-27" @default.
• W4200592904 title "Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients" @default.
• W4200592904 cites W1521268196 @default.
• W4200592904 cites W1571718974 @default.
• W4200592904 cites W1668031793 @default.
• W4200592904 cites W1890886324 @default.
• W4200592904 cites W1968550558 @default.
• W4200592904 cites W1976945512 @default.
• W4200592904 cites W1977089094 @default.
• W4200592904 cites W1985200974 @default.
• W4200592904 cites W1987424918 @default.
• W4200592904 cites W1990251709 @default.
• W4200592904 cites W1998369303 @default.
• W4200592904 cites W2002330265 @default.
• W4200592904 cites W2023731159 @default.
• W4200592904 cites W2030721665 @default.
• W4200592904 cites W2038762279 @default.
• W4200592904 cites W2047414650 @default.
• W4200592904 cites W2047697804 @default.
• W4200592904 cites W2071518542 @default.
• W4200592904 cites W2080517288 @default.
• W4200592904 cites W2094648371 @default.
• W4200592904 cites W2102182695 @default.
• W4200592904 cites W2109057881 @default.
• W4200592904 cites W2109374123 @default.
• W4200592904 cites W2112125919 @default.
• W4200592904 cites W2114634451 @default.
• W4200592904 cites W2128606426 @default.
• W4200592904 cites W2135398118 @default.
• W4200592904 cites W2135916759 @default.
• W4200592904 cites W2150784673 @default.
• W4200592904 cites W2154258710 @default.
• W4200592904 cites W2155018999 @default.
• W4200592904 cites W2157559566 @default.
• W4200592904 cites W2167018359 @default.
• W4200592904 cites W2315104804 @default.
• W4200592904 cites W2405485021 @default.
• W4200592904 cites W2427094903 @default.
• W4200592904 cites W2557460830 @default.
• W4200592904 cites W2620245977 @default.
• W4200592904 cites W2740251705 @default.
• W4200592904 cites W2807167744 @default.
• W4200592904 cites W2808184177 @default.
• W4200592904 cites W2887056153 @default.
• W4200592904 cites W2919599981 @default.
• W4200592904 cites W2953297131 @default.
• W4200592904 cites W2963126389 @default.
• W4200592904 cites W3049746601 @default.
• W4200592904 cites W3110029778 @default.
• W4200592904 cites W4246681983 @default.
• W4200592904 doi "https://doi.org/10.3389/fcvm.2021.761537" @default.
• W4200592904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35004879" @default.
• W4200592904 hasPublicationYear "2021" @default.
• W4200592904 type Work @default.
• W4200592904 citedByCount "3" @default.
• W4200592904 countsByYear W42005929042022 @default.
• W4200592904 countsByYear W42005929042023 @default.
• W4200592904 crossrefType "journal-article" @default.
• W4200592904 hasAuthorship W4200592904A5002588547 @default.
• W4200592904 hasAuthorship W4200592904A5004309205 @default.
• W4200592904 hasAuthorship W4200592904A5034321470 @default.
• W4200592904 hasAuthorship W4200592904A5034875129 @default.
• W4200592904 hasAuthorship W4200592904A5050638924 @default.
• W4200592904 hasAuthorship W4200592904A5070105880 @default.
• W4200592904 hasAuthorship W4200592904A5072129602 @default.
• W4200592904 hasAuthorship W4200592904A5087944559 @default.
• W4200592904 hasBestOaLocation W42005929041 @default.
• W4200592904 hasConcept C126322002 @default.
• W4200592904 hasConcept C134018914 @default.
• W4200592904 hasConcept C164705383 @default.
• W4200592904 hasConcept C207103383 @default.
• W4200592904 hasConcept C2777391703 @default.
• W4200592904 hasConcept C2778198053 @default.
• W4200592904 hasConcept C2778213512 @default.
• W4200592904 hasConcept C2779306644 @default.
• W4200592904 hasConcept C44249647 @default.
• W4200592904 hasConcept C50382708 @default.
• W4200592904 hasConcept C555293320 @default.
• W4200592904 hasConcept C68443243 @default.
• W4200592904 hasConcept C71924100 @default.
• W4200592904 hasConcept C78085059 @default.
• W4200592904 hasConceptScore W4200592904C126322002 @default.
• W4200592904 hasConceptScore W4200592904C134018914 @default.
• W4200592904 hasConceptScore W4200592904C164705383 @default.
• W4200592904 hasConceptScore W4200592904C207103383 @default.
• W4200592904 hasConceptScore W4200592904C2777391703 @default.
• W4200592904 hasConceptScore W4200592904C2778198053 @default.
• W4200592904 hasConceptScore W4200592904C2778213512 @default.
• W4200592904 hasConceptScore W4200592904C2779306644 @default.

• next